CANTEX

Cantex is developing azeliragon, a novel antagonist of RAGE (the receptor for advanced glycation endproducts)... Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company developing novel, well-tolerated, oral treatments of cancer and other serious illnesses... We are a clinical stage pharmaceutical company focused on developing novel, well-tolerated, once-daily oral treatments for cancer, and other serious illnesses.

Also known as: Cantex Pharmaceuticals, Cantex Pharmaceuticals, Inc.

Primary location: Weston United States